Sharon Bio-Medicine Ltd has completed expansion at its three manufacturing facilities. The total investment in expansion has been incurred to the tune nearly Rs 125 crores. In Dehradun formulation plant, the expanded expenditure has been approximately Rs 85 crores whereas capacity of the plant has been increased more than double. Similarly, other plants’ capacity has been added between 30% to 50%.
“The commercial production in Sharon two expanded plants at Taloja near Navi Mumbai have already been started and Dehradun formulation expanded facility will start production from June 2014,” said the company in BSE filing.
“The commercial production in Sharon two expanded plants at Taloja near Navi Mumbai have already been started and Dehradun formulation expanded facility will start production from June 2014,” said the company in BSE filing.